Information:
Error:
ID
34354
Description
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01287715
Link
https://clinicaltrials.gov/show/NCT01287715
Keywords
Versions (1)
- 1/16/19 1/16/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 16, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Juvenile Idiopathic Arthritis NCT01287715
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Similar models
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
diagnosis of juvenile idiopathic arthritis (all subtypes) by the international league of associations of rheumatology (ilar) criteria
boolean
ID.2
Item
on etanercept therapy
boolean
ID.3
Item
no mtx or low dose mtx (maximum 10 mg/m2)
boolean
ID.4
Item
3 or more months in remission according to the criteria of wallace (i.e. 9 or more months of inactive disease)
boolean
ID.5
Item
age ≥4 and <18 years at start of study
boolean
ID.6
Item
written informed consent from parents and patients 12 years and over
boolean
ID.7
Item
systemic corticosteroids (up to 9 months prior to inclusion)
boolean
ID.8
Item
intra-articular corticosteroids (up to 6 months prior to inclusion)
boolean
ID.9
Item
synthetic dmards besides low dose mtx (up to 9 months prior to inclusion)
boolean
ID.10
Item
biologic dmards besides etanercept (up to 9 months prior to inclusion)
boolean